Hans-Reiner Figulla
Directeur Général chez devie medical GmbH
Profil
Hans-Reiner Figulla is the founder of JenaValve Technology GmbH and JenaValve Technology, Inc. both founded in 2006.
He is currently the Managing Director at devie medical GmbH since 2018.
He previously worked as Clinic Director & Professor at Friedrich Schiller University of Jena and as a Professor at the University of Gottingen.
Postes actifs de Hans-Reiner Figulla
| Sociétés | Poste | Début |
|---|---|---|
devie medical GmbH
 devie medical GmbH Medical SpecialtiesHealth Technology devie medical GmbH engages in the development, production, and distribution of drug-eluting heart valve. The company was founded in 2018 and is headquartered in Jena, Germany. | Directeur Général | 19/02/2018 |
Anciens postes connus de Hans-Reiner Figulla
| Sociétés | Poste | Fin |
|---|---|---|
JenaValve Technology, Inc.
 JenaValve Technology, Inc. Medical SpecialtiesHealth Technology JenaValve Technology, Inc. designs, develops, manufactures, and markets transcatheter aortic valve replacement systems. The company was founded on March 27, 2006 and is headquartered in Wilmington, DE. | Fondateur | - |
| University of Gottingen | Corporate Officer/Principal | - |
JenaValve Technology GmbH
 JenaValve Technology GmbH Medical SpecialtiesHealth Technology JenaValve Technology GmbH develops and manufactures transcatheter valve implantation systems for transapical and transfemoral implantation. The firm offers a therapeutic alternative to surgical aortic valve replacement for high-risk patients suffering from aortic heart valve stenosis. The company was founded by Markus Ferrari, Volker Guyenot and Hans-Reiner Figulla in 2006 and is headquartered in Munich, Germany. | Fondateur | - |
| Friedrich Schiller University of Jena | Directeur Technique/Scientifique/R&D | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 3 |
|---|---|
JenaValve Technology GmbH
JenaValve Technology GmbH Medical SpecialtiesHealth Technology JenaValve Technology GmbH develops and manufactures transcatheter valve implantation systems for transapical and transfemoral implantation. The firm offers a therapeutic alternative to surgical aortic valve replacement for high-risk patients suffering from aortic heart valve stenosis. The company was founded by Markus Ferrari, Volker Guyenot and Hans-Reiner Figulla in 2006 and is headquartered in Munich, Germany. | Health Technology |
JenaValve Technology, Inc.
JenaValve Technology, Inc. Medical SpecialtiesHealth Technology JenaValve Technology, Inc. designs, develops, manufactures, and markets transcatheter aortic valve replacement systems. The company was founded on March 27, 2006 and is headquartered in Wilmington, DE. | Health Technology |
devie medical GmbH
devie medical GmbH Medical SpecialtiesHealth Technology devie medical GmbH engages in the development, production, and distribution of drug-eluting heart valve. The company was founded in 2018 and is headquartered in Jena, Germany. | Health Technology |
